DNA Polymerase Market size is estimated at USD 348.9 million in 2024 and is set to cross USD 762.6 million by the end of 2037, registering more than 6.2% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of DNA polymerase is evaluated at USD 370.5 million.
The growing emphasis on genetic research, including gene sequencing, genome editing, and personalized medicine, drives demand for high-quality DNA polymerase. DNA polymerases are essential for various next-generation sequencing (NGS) platforms, which are widely used in genomics research. Companies such as Illumina and Thermo Fisher Scientific rely on high-quality DNA polymerases for their sequencing technologies. Moreover, CRISPR-Cas9 and other gene editing technologies require precise DNA polymerases for accurate editing and validation.
Additionally, chronic diseases such as cancer, diabetes, and cardiovascular conditions often require advanced diagnostic tools for early detection and ongoing monitoring. For instance, according to the World Health Organization (WHO), globally, cardiovascular diseases (CVDs) account for 17.9 million deaths annually. DNA polymerases are integral to techniques such as Polymerase Chain Reaction (PCR), and NGS, which are used to identify genetic markers and mutations associated with these diseases.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.2% |
|
Base Year Market Size (2024) |
USD 348.9 million |
|
Forecast Year Market Size (2037) |
USD 762.6 million |
|
Regional Scope |
|
Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends)
Taq polymerase segment is likely to capture over 50.3% DNA polymerase market share by 2037. By amplifying a particular DNA sequence, the method facilitates analysis and investigation. The ability of Taq polymerases to tolerate high temperatures and their high processivity, which allows them to stretch DNA strands quickly and effectively, are two features that make them very helpful for PCR. During the COVID-19 pandemic, there was a sharp increase in demand for these DNA polymerases since the pandemic spurred various genetics and molecular biology research opportunities.
Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning)
The polymerase chain reaction segment in DNA polymerase market is expected to garner a notable share in the forecast period. The segment growth can be attributed to the increased adoption of this technology in several molecular biology techniques. PCR technology is essential in many domains, including biotechnology, forensic sciences, and medical diagnostics, where it can be applied to DNA-based research and the creation of new products. For instance, PCR tests are used for diagnosing diseases such as tuberculosis, HIV, and various other bacterial and viral infections.
Moreover, PCR is also used in forensic and legal applications. In forensic science, PCR is used to amplify and analyze DNA from crime scenes. This application has a major impact on forensic investigations and paternity tests.
End use (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals & Diagnostic Centers)
The hospitals & diagnostics centers segment in DNA polymerase market is estimated to gain a significant revenue share in 2037. The segment growth can be attributed to the growing incidence of genetic disorders and infectious diseases, which have increased the demand for PCR testing by these facilities for diagnosis. According to the WHO, in developed nations, genetic illnesses and congenital abnormalities cause over 50% of childhood fatalities, account for up to 30% of pediatric hospital admissions, and affect 2%–5% of live births.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Application |
|
|
End use |
|
North America Market Statistics
North America in DNA polymerase market is expected to account for more than 37% revenue share by the end of 2037. The market growth in the region is expected on account of the presence of well-known biotech and pharmaceutical companies highly investing in the development of novel medications and treatments. These businesses drive the need for DNA polymerases, which depend on them for numerous applications like PCR, sequencing, and genetic engineering.
The U.S. healthcare industry has opportunities for profitable growth due to its easy access to capital and investments in cutting-edge infrastructure. Additionally, a number of contract manufacturing and bioprocessing firms around the country are driving the expansion of the DNA polymerase market. National development will also be aided by financing for the manufacturing of generic biologics when pharmaceutical patents expire. Also, growing investments in healthcare is another factor propelling the market growth. According to the American Medical Association, in 2022, U.S. health spending climbed by 4.1% to reach USD 4.5 trillion, or USD 13,493 per person.
In Canada DNA polymerase has been increasingly used in biotechnology labs for DNA replication. The growth in chronic conditions such as cancer and diabetes is driving the expansion, and this is expected to support market growth in the country. According to the local government, after accounting for the aging population over time, the prevalence of diabetes has been rising at an average annual rate of 3.3% for nearly 3 million Canadians, or 8.9% of the total population.
APAC Market Analysis
APAC will witness huge growth in the DNA polymerase market during the forecast period. The growth can be ascribed to the high prevalence of target diseases, rising financing for genomic research, and growing public awareness of genetic testing in the region. Furthermore, domestic and international market players are highly investing in the development of innovative DNA polymerases, which is anticipated to accelerate the region's growth.
The biopharmaceutical industry in China is expected to have favorable growth prospects due to the relocation of drug production facilities by international manufacturers and the presence of various biopharmaceutical contract research companies within the country. According to a 2024 report by the IMD Organization, prominent pharmaceutical corporations have been emphasizing the acquisition of and investment in forward-thinking regional businesses to further integrate themselves into the national Chinese biotech ecosystem. For instance, AstraZeneca is spending USD 1 billion to purchase Gracell Biotechnologies, a leader in CAR-T technology, in the first-ever full acquisition of a cutting-edge Chinese biotech company by a "Big Pharma" corporation.
In India, innovations such as real-time PCR (qPCR), digital PCR (dPCR), and next-generation sequencing have revolutionized the field of molecular diagnostics. Furthermore, the growing applications of PCR technology in oncology is contributing to the expansion of the DNA polymerase market. According to the National Centre for Disease Informatics and Research, with a crude incidence rate of 100.4 cases per 100,000 people, 1,461,427 new cases of cancer were diagnosed in India in 2022. Therefore, the growth in cancer cases will significantly drive the DNA polymerase market.
South Korea's biotechnology industry is booming, with numerous companies and academic institutions actively engaged in developing and utilizing DNA polymerase. For instance, The Korean Agency for Technology and Standards (KATS) Biotechnology Classification Code projected that the output volume of the biotech industry would be around USD 16 million in 2021. Over the last five years, there has been an average yearly increase of 17.8%, compared to figures below USD 75 billion in 2016.
The DNA polymerase market is highly concentrated worldwide, with major biopharmaceutical companies controlling a sizable portion of the market. Major industry participants are investigating new applications in compliance with local, state, federal, and global regulatory norms, and concentrating more on product research and launch.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?